266 related articles for article (PubMed ID: 12481024)
1. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts.
Rogatsky I; Luecke HF; Leitman DC; Yamamoto KR
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16701-6. PubMed ID: 12481024
[TBL] [Abstract][Full Text] [Related]
2. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
3. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
[TBL] [Abstract][Full Text] [Related]
4. FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors.
Kino T; Ichijo T; Chrousos GP
J Steroid Biochem Mol Biol; 2004 Dec; 92(5):357-63. PubMed ID: 15698540
[TBL] [Abstract][Full Text] [Related]
5. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
6. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones.
Rogatsky I; Zarember KA; Yamamoto KR
EMBO J; 2001 Nov; 20(21):6071-83. PubMed ID: 11689447
[TBL] [Abstract][Full Text] [Related]
7. The nuclear isoform of the LIM domain protein Trip6 integrates activating and repressing signals at the promoter-bound glucocorticoid receptor.
Diefenbacher ME; Litfin M; Herrlich P; Kassel O
Mol Cell Endocrinol; 2010 May; 320(1-2):58-66. PubMed ID: 20153803
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of NF-kappa B binding correlates with increased nuclear glucocorticoid receptor levels in acute alcohol-treated human monocytes.
Mandrekar P; Bellerose G; Szabo G
Alcohol Clin Exp Res; 2002 Dec; 26(12):1872-9. PubMed ID: 12500112
[TBL] [Abstract][Full Text] [Related]
9. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
[TBL] [Abstract][Full Text] [Related]
10. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
Cho S; Blackford JA; Simons SS
Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor.
Almawi WY; Melemedjian OK
J Leukoc Biol; 2002 Jan; 71(1):9-15. PubMed ID: 11781376
[TBL] [Abstract][Full Text] [Related]
12. DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells--toward a basis for the opposite actions elicited by two nuclear receptors?
Obradović D; Tirard M; Némethy Z; Hirsch O; Gronemeyer H; Almeida OF
Mol Pharmacol; 2004 Mar; 65(3):761-9. PubMed ID: 14978255
[TBL] [Abstract][Full Text] [Related]
13. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression.
Reily MM; Pantoja C; Hu X; Chinenov Y; Rogatsky I
EMBO J; 2006 Jan; 25(1):108-17. PubMed ID: 16362036
[TBL] [Abstract][Full Text] [Related]
14. Modulation of glucocorticoid receptor-interacting protein 1 (GRIP1) transactivation and co-activation activities through its C-terminal repression and self-association domains.
Liu PY; Hsieh TY; Chou WY; Huang SM
FEBS J; 2006 May; 273(10):2172-83. PubMed ID: 16649994
[TBL] [Abstract][Full Text] [Related]
15. The promoter context determines mutual repression or synergism between NF-kappaB and the glucocorticoid receptor.
Hofmann TG; Schmitz ML
Biol Chem; 2002 Dec; 383(12):1947-51. PubMed ID: 12553732
[TBL] [Abstract][Full Text] [Related]
16. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
[TBL] [Abstract][Full Text] [Related]
17. Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain.
Bodwell JE; Kingsley LA; Hamilton JW
Chem Res Toxicol; 2004 Aug; 17(8):1064-76. PubMed ID: 15310238
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII): implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism.
De Martino MU; Alesci S; Chrousos GP; Kino T
Ann N Y Acad Sci; 2004 Jun; 1024():72-85. PubMed ID: 15265774
[TBL] [Abstract][Full Text] [Related]
19. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor.
Reichardt HM; Tuckermann JP; Göttlicher M; Vujic M; Weih F; Angel P; Herrlich P; Schütz G
EMBO J; 2001 Dec; 20(24):7168-73. PubMed ID: 11742993
[TBL] [Abstract][Full Text] [Related]
20. Polyamine-modulated factor 1 represses glucocorticoid receptor activity.
Shoji Y; Osman W; Zilliacus J
Biochem Biophys Res Commun; 2007 Sep; 361(1):176-81. PubMed ID: 17637456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
